IRadimed Corporation (IRMD) Stock Forecast
Data as of May 2, 2026Healthcare · Current price $86.51 (+3.68%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Nov 3, 2025 | Kyle Bauser | Roth Capital | $98.00 | +13.3% |
| Oct 31, 2025 | Kyle Bauser | Roth Capital | $90.00 | +4.0% |
| Aug 2, 2024 | Jason Wittes | Roth Capital | $60.00 | -30.6% |
| Jun 17, 2024 | Frank Takkinen | Loop Capital Markets | $60.00 | -30.6% |
Top Analysts Covering IRMD
IRMD vs Sector & Market
| Metric | IRMD | Healthcare Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | — | 2.24 | 2.41 |
| Analyst Count | — | 8 | 18 |
| Target Upside | +38.7% | +1150.2% | +14.9% |
| P/E Ratio | 49.43 | 6.82 | 31.19 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-06-30 | $21M | $21M | $21M | 1 |
| 2026-09-30 | $24M | $24M | $24M | 1 |
| 2026-12-31 | $26M | $26M | $26M | 1 |
| 2027-03-31 | $23M | $23M | $23M | 1 |
| 2027-06-30 | $25M | $25M | $25M | 1 |
| 2027-09-30 | $26M | $26M | $26M | 1 |
| 2027-12-31 | $27M | $27M | $27M | 1 |
| 2028-12-31 | $120M | $121M | $122M | 1 |
| 2029-12-31 | $131M | $132M | $133M | 1 |
| 2030-12-31 | $144M | $146M | $147M | 1 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-06-30 | $0.46 | $0.47 | $0.47 | 1 |
| 2026-09-30 | $0.54 | $0.55 | $0.55 | 1 |
| 2026-12-31 | $0.61 | $0.61 | $0.62 | 1 |
| 2027-03-31 | $0.49 | $0.49 | $0.49 | 1 |
| 2027-06-30 | $0.54 | $0.54 | $0.54 | 1 |
| 2027-09-30 | $0.59 | $0.59 | $0.59 | 1 |
| 2027-12-31 | $0.62 | $0.62 | $0.62 | 1 |
| 2028-12-31 | $2.63 | $2.67 | $2.71 | 1 |
| 2029-12-31 | $3.00 | $3.04 | $3.08 | 1 |
| 2030-12-31 | $3.38 | $3.43 | $3.48 | 1 |
Frequently Asked Questions
What is the analyst consensus for IRMD?
The consensus among 0 analysts covering IRadimed Corporation (IRMD) is — with an average price target of $120.00.
What is the highest price target for IRMD?
The highest price target for IRMD is $98.00, set by Kyle Bauser at Roth Capital on 2025-11-03.
What is the lowest price target for IRMD?
The lowest price target for IRMD is $60.00, set by Frank Takkinen at Loop Capital Markets on 2024-06-17.
How many analysts cover IRMD?
0 analysts have issued ratings for IRadimed Corporation in the past 12 months.
Is IRMD a buy or sell right now?
Based on 0 analyst ratings, IRMD has a consensus rating of — with a +38.7% upside to the consensus target of $120.00.
What are the earnings estimates for IRMD?
Analysts estimate IRMD will report EPS of $0.47 for the period ending 2026-06-30, with revenue estimated at $21M.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.